Metraipolis › archive › dc_019fbeb25636

Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System — Europe PMC PMID:41474629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41474629
DOI
10.1002/cam4.71467
License (as archived)
solo-consultazione
Archived
2026-11-07T06:25:32.112Z
SHA-256 of the archived text
dc674b2b4f06390722130498a8c0bd4a5424e09b3d4a5c8366a07e1088b59e5b
Stable URL of this page
https://metraipolis.com/documento/dc_019fbeb25636

How to cite

Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System — Europe PMC PMID:41474629 — Europe PMC (en), https://europepmc.org/article/MED/41474629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_019fbeb25636 (Metraipolis archive dc_019fbeb25636, sha256 dc674b2b4f06390722130498a8c0bd4a5424e09b3d4a5c8366a07e1088b59e5b)
BibTeX
@misc{dc019fbeb25636,
  title = {Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System — Europe PMC PMID:41474629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41474629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_019fbeb25636; sha256 dc674b2b4f06390722130498a8c0bd4a5424e09b3d4a5c8366a07e1088b59e5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41474629. Agents can read the archived copy with the MCP tool read_document.